Axsome Therap
AXSM----
Axsome Therap (AXSM)
Axsome Therapeutics, Inc., a biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in th...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Axsome Therap Analyst Rating
View MoreForecast & Rating
Jul 21, 2026Price forecast
$282.5117.23%
Forecast & RatingStrong buy
21analysts
- Strong buy80.95%
- Buy14.29%
- Hold4.76%
- Sell0.00%
- Strong sell0.00%
News
- Market Beat · 17 hours ago
Illinois Municipal Retirement Fund Invests $884,000 in Axsome Therapeutics, Inc. $AXSM
- benzinga_article · Jul 21 at 06:58 AM
This Insmed Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
- Market Beat · Jul 15 at 12:42 PM
Axsome Therapeutics' (AXSM) "Buy" Rating Reiterated at HC Wainwright
- PUBT · Jul 15 at 06:02 AM
Axsome says FDA accepts AXS-12 narcolepsy cataplexy NDA, sets May 1, 2027 PDUFA date
- PUBT · Jul 14 at 06:00 AM
Axsome Therapeutics to report Q2 financial results, host conference call
- Motley Fool · Jul 10 at 01:40 PM
3 Under-the-Radar Stocks to Buy and Hold
